C85.89
Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Non-Hodgkin lymphoma (NHL) is a diverse group of blood cancers originating in the lymphatic system, which is part of the body's immune system. The ICD-10 code C85.89 pertains to specific types of NHL that occur outside the lymph nodes, known as extranodal sites, and involve solid organs. These variations can differ widely in their behavior, treatment options, and prognosis, making awareness and understanding crucial for affected individuals.
Causes & Symptoms
Clinical Causes: Weakened immune system due to conditions like HIV/AIDS or immunosuppressive therapy Infections caused by viruses such as Epstein-Barr virus (EBV), Human T-cell lymphotropic virus (HTLV-1), and Helicobacter pylori Exposure to certain chemicals or pesticides A history of autoimmune diseases like rheumatoid arthritis or Sjögren’s syndrome Previous radiation therapy or chemotherapy for other cancers Age, as the risk increases with advancing age Genetic predispositions or family history of lymphoma
Key Symptoms: Persistent swelling or a lump in the affected area, such as the abdomen, chest, or other organs Unexplained weight loss Fever that doesn't resolve Night sweats and chills Fatigue and weakness Pain or discomfort in the affected region Absence of typical lymph node enlargement in cases where extranodal sites are involved Organ-specific symptoms, like difficulty breathing if the lungs are involved or abdominal pain with gastrointestinal involvement
Diagnostic & Treatment
Diagnosis Path: Physical examination and medical history review Imaging studies such as CT scans, PET scans, or MRI to locate and assess affected organs Biopsy of the affected tissue to confirm the presence of lymphoma cells and determine the subtype Laboratory tests including blood counts and flow cytometry Additional tests like bone marrow biopsies or specific molecular studies to identify genetic markers
Treatment Protocols: Chemotherapy protocols tailored to the specific subtype and site involvement Targeted therapy that focuses on specific molecules involved in cancer growth Radiation therapy, particularly for localized extranodal tumors Immunotherapy options, such as monoclonal antibodies, to boost the immune response Stem cell transplantation in advanced cases or relapsed disease Supportive care including medications to manage symptoms, infections, or side effects of treatment
Clinical Advice & FAQs
Billing Guidance
Is C85.89 a billable ICD-10 code?
Yes, C85.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.89?
Clinical documentation must specify the nature of Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
